Shandong Keyuan Pharmaceutical Co., Ltd. (SHE:301281)

China flag China · Delayed Price · Currency is CNY
33.75
+2.71 (8.73%)
At close: Jul 31, 2026
Market Cap3.65B -11.6%
Revenue (ttm)448.33M +4.6%
Net Income23.54M -62.0%
EPS0.21 -62.9%
Shares Out 108.29M
PE Ratio158.21
Forward PEn/a
Dividend0.05 (0.15%)
Ex-Dividend DateJun 16, 2026
Volume4,409,493
Open31.40
Previous Close31.04
Day's Range31.39 - 34.42
52-Week Range25.87 - 59.24
Beta-0.05
Analystsn/a
Price Targetn/a
Earnings DateAug 27, 2026

About SHE:301281

Shandong Keyuan Pharmaceutical Co., Ltd. is involved in the research and development, manufacture, and marketing of chemical raw materials and their preparations. It offers gliclazide; metformin hydrochloride; isosorbide mononitrate; isosorbide dinitrate; lansoprazole; mecobalamin; ropivacaine hydrochloride; isoflurane; fluoxetine hydrochloride; clarithromycin L-lactate; chlorpheniramine maleate; esmolol hydrochloride; isoproterenol hydrochloride; nicotinamide-tinidazole; aminolevulinate; nisoldipine; qupibutu; propafenone hydrochloride; potass... [Read more]

Sector Healthcare
Founded 2004
Employees 650
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 301281
Full Company Profile

Financial Performance

In 2025, SHE:301281's revenue was 398.23 million, a decrease of -14.12% compared to the previous year's 463.72 million. Earnings were 16.55 million, a decrease of -72.62%.

Financial Statements